Picture of BACHEM HOLDING AG logo

BANB BACHEM HOLDING AG Share Price

0.000.00%
ch flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m+21.87%
3m+20.45%
6m+8.43%
1yr-18.64%
Volume Change (%)
10d/3m-9.53%
Price vs... (%)
52w High-21.21%
50d MA+24.12%
200d MA+16.94%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)49.44
PEG Ratio (f)5.12
EPS Growth (f)10.68%
Dividend Yield (f)1.03%
Valuation (ttm)IndustryMarket
Price to Book Value4.72
Price to Tang. Book4.77
Price to Free Cashflown/a
Price to Sales10.8
EV to EBITDA35.67

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital8.49%
Return on Equity8.98%
Operating Margin22.32%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueCH₣m313.71402503.23531.74577.32668.56826.615.37%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+14.02+42.54+45.05-15.64+10.12+4.87+29.49n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of BACHEM HOLDING AG EPS forecast chart

Profile Summary

Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The Company markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
June 16th, 1971
Public Since
June 29th, 2001
No. of Employees
2,006
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
ch flag iconSIX Swiss Exchange
Shares in Issue
74,973,645

BANB Share Price Performance

Upcoming Events for BANB

Bachem Holding AG Annual Shareholders Meeting

Dividend For BANB.S - 0.4000 CHF

Dividend For BANB.S - 0.4000 CHF

Half Year 2024 Bachem Holding AG Earnings Release

Similar to BANB

Picture of Addex Therapeutics logo

Addex Therapeutics

ch flag iconSIX Swiss Exchange

Picture of BB Biotech AG logo

BB Biotech AG

ch flag iconSIX Swiss Exchange

Picture of Idorsia logo

Idorsia

ch flag iconSIX Swiss Exchange

FAQ